Business Description
Bone Biologics Corporation is a US-based medical company founded in 2004 and headquartered in Burlington, Massachusetts, that develops advanced solutions for spinal bone regeneration. Its main product, NELL-1/DBM, uses a lab-engineered protein to promote precise and targeted bone growth, with applications in spinal fusion, trauma cases, and osteoporosis treatment. The company holds a licensing agreement with UCLA to develop and bring these treatments to market, ultimately serving spine surgeons and patients dealing with bone defects or spinal conditions.
